Lifecore Biomedical, Inc. \De\ financial data

Symbol
LFCR on Nasdaq
Location
3515 Lyman Boulevard, Chaska, MN
Fiscal year end
May 25
Latest financial report
10-K - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 238 % +13.6%
Quick Ratio 108 % +0.19%
Debt-to-equity 5.21K % +8.49%
Return On Assets -15.8 % -426%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 37.4M shares +21.2%
Common Stock, Shares, Outstanding 37M shares +21.1%
Entity Public Float 202M USD +31%
Common Stock, Value, Issued 37K USD +19.4%
Weighted Average Number of Shares Outstanding, Basic 34.8M shares +14.3%
Weighted Average Number of Shares Outstanding, Diluted 34.8M shares -5.02%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 8.26M USD -3.7%
Operating Income (Loss) -17.2M USD -95%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -38.7M USD -506%
Income Tax Expense (Benefit) 43K USD -76.5%
Net Income (Loss) Attributable to Parent -38.7M USD -422%
Earnings Per Share, Basic -1 USD/shares -426%
Earnings Per Share, Diluted -1 USD/shares -485%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.27M USD -2.33%
Accounts Receivable, after Allowance for Credit Loss, Current 30.3M USD
Inventory, Net 32.3M USD -19.2%
Assets, Current 85.7M USD +5.73%
Property, Plant and Equipment, Net 129M USD -13.5%
Operating Lease, Right-of-Use Asset 2.23M USD -11%
Intangible Assets, Net (Excluding Goodwill) 4.2M USD 0%
Goodwill 13.9M USD 0%
Other Assets, Noncurrent 6.58M USD +15.8%
Assets 239M USD -5.76%
Accounts Payable, Current 8.22M USD -49.7%
Employee-related Liabilities, Current 6.14M USD -0.34%
Accrued Liabilities, Current 22M USD -2.57%
Contract with Customer, Liability, Current 3.42M USD +61.6%
Liabilities, Current 30.2M USD -22.4%
Contract with Customer, Liability, Noncurrent 3.03M USD -39%
Deferred Income Tax Liabilities, Net 552K USD +32.7%
Operating Lease, Liability, Noncurrent 1.34M USD -22.3%
Other Liabilities, Noncurrent 9.74M USD -19.2%
Liabilities 192M USD -4.07%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -205M USD -23.3%
Stockholders' Equity Attributable to Parent 1.34M USD -88.2%
Liabilities and Equity 239M USD -5.76%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -643K USD +92.3%
Net Cash Provided by (Used in) Financing Activities 1.09M USD -62.7%
Net Cash Provided by (Used in) Investing Activities -3.39M USD +32.9%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 37M shares +21.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.94M USD +71.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.27M USD -2.33%
Deferred Tax Assets, Valuation Allowance 54.7M USD +18.5%
Deferred Tax Assets, Gross 73.5M USD +9.96%
Operating Lease, Liability 1.73M USD -69.6%
Payments to Acquire Property, Plant, and Equipment 3.39M USD -32.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12M USD +82%
Lessee, Operating Lease, Liability, to be Paid 1.88M USD -68.1%
Property, Plant and Equipment, Gross 186M USD -6.56%
Operating Lease, Liability, Current 387K USD -90.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 416K USD -3.93%
Lessee, Operating Lease, Liability, to be Paid, Year One 433K USD -89.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 153K USD -27.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 302K USD -27.4%
Deferred Tax Assets, Operating Loss Carryforwards 40.7M USD -0.32%
Preferred Stock, Shares Issued 44.1K shares +7.48%
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 1.32M USD +4.09%
Lessee, Operating Lease, Liability, to be Paid, Year Four 146K USD -51.7%
Additional Paid in Capital 207M USD +16.2%
Preferred Stock, Shares Outstanding 44.1K shares +7.48%
Depreciation, Depletion and Amortization 1.99M USD -8.07%
Deferred Tax Assets, Net of Valuation Allowance 18.8M USD -9.13%
Share-based Payment Arrangement, Expense 8.88M USD +84.1%
Interest Expense 17.6M USD +13.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%